Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Their focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. Owkin uses AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables medical and biopharma partners to unlock valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data.